Determination of skeletal muscle mass by aspartate aminotransferase / alanine aminotransferase ratio, insulin and FSH in Chinese women with sarcopenia

[1]  Fing Ding,et al.  High Serum AST/ALT Ratio and Low Serum INS*PA Product Are Risk Factors and Can Diagnose Sarcopenia in Middle-Aged and Older Adults , 2022, Frontiers in Endocrinology.

[2]  M. Pawlikowski,et al.  Gonadotropins at Advanced Age - Perhaps They Are Not So Bad? Correlations Between Gonadotropins and Sarcopenia Indicators in Older Adults , 2021, Frontiers in Endocrinology.

[3]  J. Yue,et al.  Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study , 2021, Frontiers in Endocrinology.

[4]  E. Vittinghoff,et al.  Follicle-stimulating hormone level and changes in bone mass and body composition in older women and men. , 2021, The Journal of clinical endocrinology and metabolism.

[5]  J. Yue,et al.  Multiple Physical Symptoms of Community-Dwelling Older People in Western China: Prevalence and Its Association with Frailty , 2021, Gerontology.

[6]  T. Katsuya,et al.  Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study. , 2020, Journal of the American Medical Directors Association.

[7]  D. Ryu,et al.  Sarcopenia and Muscle Aging: A Brief Overview. , 2020, Endocrinology and metabolism.

[8]  A. Brom,et al.  Baseline low ALT activity is associated with increased long-term mortality after COPD exacerbations , 2020, BMC Pulmonary Medicine.

[9]  K. Moreau,et al.  Appendicular lean mass is lower in late- compared to early- perimenopausal women: potential role of FSH. , 2020, Journal of applied physiology.

[10]  J. Yue,et al.  Association Between Number of Teeth, Denture Use and Frailty: Findings from the West China Health and Aging Trend Study , 2020, The journal of nutrition, health & aging.

[11]  I. Benseñor,et al.  Thyroid Function and Sarcopenia: Results from the ELSA‐Brasil Study , 2020, Journal of the American Geriatrics Society.

[12]  L. Peng,et al.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.

[13]  C. Sieber.  Malnutrition and sarcopenia , 2019, Aging Clinical and Experimental Research.

[14]  T. Yanase,et al.  A High Serum Cortisol/DHEA-S Ratio Is a Risk Factor for Sarcopenia in Elderly Diabetic Patients , 2019, Journal of the Endocrine Society.

[15]  M. Soto,et al.  Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures , 2019, International journal of molecular sciences.

[16]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[17]  Jaekyung No,et al.  Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis , 2018, Journal of obesity & metabolic syndrome.

[18]  Huaqi Zhang,et al.  Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis , 2018, Nutrients.

[19]  T. Yuen,et al.  Epitope-specific monoclonal antibodies to FSHβ increase bone mass , 2018, Proceedings of the National Academy of Sciences.

[20]  T. Yuen,et al.  Blocking FSH induces thermogenic adipose tissue and reduces body fat , 2017, Nature.

[21]  S. Volpe,et al.  Protein and exercise in the prevention of sarcopenia and aging. , 2017, Nutrition research.

[22]  Matteo Cesari,et al.  Measurement of muscle mass in sarcopenia: from imaging to biochemical markers , 2017, Aging Clinical and Experimental Research.

[23]  J. Morley.  Hormones and Sarcopenia. , 2017, Current pharmaceutical design.

[24]  B. Dong,et al.  Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people , 2016, BMC Geriatrics.

[25]  J. Morley,et al.  Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. , 2016, Journal of the American Medical Directors Association.

[26]  Hiroyuki Umegaki,et al.  Sarcopenia and frailty in older patients with diabetes mellitus , 2016, Geriatrics & gerontology international.

[27]  D. Kiel,et al.  Developing Consensus Criteria for Sarcopenia: An Update , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  Jeffrey R Stout,et al.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.

[29]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[30]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[31]  G E Dallal,et al.  Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[32]  R. Ross,et al.  Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. , 2000, Journal of applied physiology.